Notice of General Meeting 2018

 27th Sep 2018

Download the full announcement


EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed medical diagnostics business, announces that a general meeting of the Company will be held at the offices of Harwood Capital LLP, 6 Stratton Street, Mayfair, London W1J 8LD at 11 a.m. on 19 October 2018 (the "General Meeting") for the purpose of considering and, if thought fit, approving a resolution to approve a distribution of the Company’s shareholding in Renalytix AI plc to the Company’s shareholders.


A copy of the circular containing the notice convening the General Meeting will be available today on the Company's website, www.ekfdiagnostics.com, in accordance with AIM Rule 20 and the Company’s articles of association, and it will also be posted to shareholders along with a form of proxy shortly.


Download EKF Circular 2018

 

Enquiries:

EKF Diagnostics Holdings plc
Christopher Mills, Non-Executive Chairman
Julian Baines, CEO
Richard Evans, Finance Director and COO

www.ekfdiagnostics.com
Tel: 00 44 29 2071 0570
N+1 Singer (Nomad & Broker)
Aubrey Powell / Lauren Kettle / George Tzimas (Corporate Finance)
Tom Salvesen (Corporate Broking)
Tel: 020 7496 3000

Walbrook PR Limited
Paul McManus
Lianne Cawthorne

Tel: 020 7933 8780 or
Mob: 07980 541 893 / 07584 391 303